Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Masimo (MASI) Climbs 34% on $9.9-Billion Danaher Merger
Masimo (MASI) Climbs 34% on $9.9-Billion Danaher Merger
Angelica Ballesteros
Wed, February 18, 2026 at 3:34 PM GMT+9 2 min read
In this article:
MASI
+34.22%
DHR
-2.93%
We recently published 10 Stocks Outperforming With Monstrous Gains. Masimo Corporation (NASDAQ:MASI) was one of the best performers on Tuesday.
Masimo Corp. snapped a two-day losing streak on Tuesday, soaring 34.22 percent to finish at $174.69 apiece as investors snapped up shares following news that it was set to merge with Danaher Corp. for $9.9 billion.
In a statement, Masimo Corporation (NASDAQ:MASI) said that it officially inked a definitive agreement with Danaher for the acquisition of its shares at a price of $180 apiece. The amount represented a 38.3 percent premium over its closing price of $130.15 on Friday, February 13.
The transaction is expected to be closed in the second half of the year, subject to closing conditions.
Masimo (MASI) Climbs 34% on $9.9-Billion Danaher Merger
Upon completion, Masimo Corporation (NASDAQ:MASI) will continue to be a standalone business unit and brand within Danaher’s Diagnostics segment and will operate autonomously.
“We look forward to joining Danaher and continuing our growth and momentum as the global leader in patient monitoring. Danaher shares our commitment to investing in talent and innovation and will be an ideal fit to help power the next chapter of Masimo. Importantly, becoming part of Danaher’s Diagnostics segment will strengthen our ability to scale our monitoring technologies globally and accelerate our mission of delivering Masimo innovations that empower clinicians to transform patient care,” said Masimo Corporation (NASDAQ:MASI) CEO Katie Szyman.
Masimo will report its earnings performance in the fourth quarter and full-year 2025 on February 26, but will not host an earnings call due to the transaction.
While we acknowledge the potential of MASI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey****.****
Terms and Privacy Policy
Privacy Dashboard
More Info